| Gram –ve bacterial isolates |
Total
(n = 113) | ||||||
| Antibiotics | Escherichia coli (n = 52) | Klebsiella spp (n = 10) | Pseudomonas spp (n = 25) | Proteus spp (n = 6) | Enterobacter spp (n = 2) | Citrobacter spp (n = 3) | |
| Ofloxacin | 46 (86%) | 8 (80%) | 20 (80%) | 6 (100%) | 3 (100%) | 2 (100%) | 85 (87%) |
| Levofloxacin | 50 (96%) | 10 (100%) | 23 (92%) | 6 (100%) | 3 (100%) | 2 (100%) | 94 (96%) |
| Pefloxacin | 48 (92%) | 9 (90%) | 22 (88%) | 6 (100%) | 3 (100%) | 2 (100%) | 90 (92%) |
| Ciprofloxacin | 47 (90%) | 8 (80%) | 21 (84%) | 6 (100%) | 3 (100%) | 2 (100%) | 87 (89%) |
| Amoxyl | 42 (81%) | 8 (80%) | 20 (80%) | 6 (100%) | 3 (100%) | 2 (100%) | 81 (83%) |
| Gentamycin | 43 (83%) | 7 (70%) | 18 (72%) | 6 (100%) | 2 (68%) | 1 (50%) | 77 (79%) |
| Augumentin | 27 (52%) | 5 (50%) | 18 (72%) | 3 (50%) | 3 (100%) | 1 (50%) | 57 (58%) |
| Streptomycin | 26 (50%) | 5 (100%) | 13 (52%) | 3 (50%) | 2 (68%) | 1 (50%) | 50 (51%) |
| Ceporex | 26 (50%) | 5 (50%) | 12 (30%) | 3 (50%) | 2 (68%) | 2 (100%) | 50 (51%) |
| Ampiclox | 15 (29%) | 5 (50%) | 9 (36%) | 3 (50%) | 0 (0%) | 2 (100%) | 34 (35%) |